John T Tlhakanelo, John Ele-Ojo Ataguba, Vincent Pagiwa, Nankie Ramabu, Khutsafalo Kadimo, Dintle Molosiwa, Grace Njeri Muriithi, Daniel Malik Achala, Elizabeth Naa Adukwei Adote, Chinyere Ojiugo Mbachu, Senait Alemayehu Beshah, Nyasha Masuka, Chijioke Osinachi Nwosu, James Akazili, Chikezie Ifeanyi
{"title":"Equitable access to COVID-19 vaccines in Botswana: a scoping review.","authors":"John T Tlhakanelo, John Ele-Ojo Ataguba, Vincent Pagiwa, Nankie Ramabu, Khutsafalo Kadimo, Dintle Molosiwa, Grace Njeri Muriithi, Daniel Malik Achala, Elizabeth Naa Adukwei Adote, Chinyere Ojiugo Mbachu, Senait Alemayehu Beshah, Nyasha Masuka, Chijioke Osinachi Nwosu, James Akazili, Chikezie Ifeanyi","doi":"10.3389/frhs.2025.1609089","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Despite global market complexities, Botswana acquired about 2.6 million COVID-19 vaccine doses between March 2021 and March 2022, 76% of which were purchased while 24% were donations. Thus, the study was envisaged to aggregate evidence on the case of Botswana's COVID-19 vaccine access patterns, hesitancy, and uptake.</p><p><strong>Materials and methods: </strong>We conducted a scoping reviewof Botswana-based articles using a predetermined search strategy to search databases including Medline, CINAHL, Web of Science, PubMed, Scopus, and Google Scholar. The review included all the English-language written peer-reviewed and grey literature reporting on vaccination in Botswana, to broaden coverage in recognition of limited publications on COVID-19 vaccinartion in Botswana. Non-English articles were excluded due to limited translation resources. Due to the heterogeneity of studies, a narrative synthesis approach was used to collect, synthesize, and map the literature.</p><p><strong>Results: </strong>As of 31 December 2021, 80.6% of the Botswana national target of 1,390,856 people over 18 years had received at least one dose of a COVID-19 vaccine, while 71.9% were fully vaccinated. Various vaccine distribution channels were utilized, including public facilities and outreaches, to improve access and uptake of vaccines. COVID-19 vaccine acceptance was considered generally high (73.4% amongst adults), and found positively associated with the male gender, those with comorbidities, those with non-restrictive religious beliefs, and those aged 55-64 years who thought the vaccine was safe for use. COVID-19 vaccine delivery relied on existing Expanded Program on Immunization (EPI) structures and therefore experienced to existing EPI challenges including, lack of transport, shortage of human resources, and vaccine stock-outs.</p><p><strong>Conclusions: </strong>Under-performance of immunization programs at the district level, characterized by declining immunization coverage and inadequate outreach services, exacerbates disparities in vaccine access. Efforts to strengthen healthcare infrastructure and expand outreach services are essential for reaching populations with limited access to healthcare facilities, particularly in rural and hard-to-reach areas. Collaboration with other government entities and the private sector improved vaccine access.</p>","PeriodicalId":73088,"journal":{"name":"Frontiers in health services","volume":"5 ","pages":"1609089"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12339540/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in health services","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/frhs.2025.1609089","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Despite global market complexities, Botswana acquired about 2.6 million COVID-19 vaccine doses between March 2021 and March 2022, 76% of which were purchased while 24% were donations. Thus, the study was envisaged to aggregate evidence on the case of Botswana's COVID-19 vaccine access patterns, hesitancy, and uptake.
Materials and methods: We conducted a scoping reviewof Botswana-based articles using a predetermined search strategy to search databases including Medline, CINAHL, Web of Science, PubMed, Scopus, and Google Scholar. The review included all the English-language written peer-reviewed and grey literature reporting on vaccination in Botswana, to broaden coverage in recognition of limited publications on COVID-19 vaccinartion in Botswana. Non-English articles were excluded due to limited translation resources. Due to the heterogeneity of studies, a narrative synthesis approach was used to collect, synthesize, and map the literature.
Results: As of 31 December 2021, 80.6% of the Botswana national target of 1,390,856 people over 18 years had received at least one dose of a COVID-19 vaccine, while 71.9% were fully vaccinated. Various vaccine distribution channels were utilized, including public facilities and outreaches, to improve access and uptake of vaccines. COVID-19 vaccine acceptance was considered generally high (73.4% amongst adults), and found positively associated with the male gender, those with comorbidities, those with non-restrictive religious beliefs, and those aged 55-64 years who thought the vaccine was safe for use. COVID-19 vaccine delivery relied on existing Expanded Program on Immunization (EPI) structures and therefore experienced to existing EPI challenges including, lack of transport, shortage of human resources, and vaccine stock-outs.
Conclusions: Under-performance of immunization programs at the district level, characterized by declining immunization coverage and inadequate outreach services, exacerbates disparities in vaccine access. Efforts to strengthen healthcare infrastructure and expand outreach services are essential for reaching populations with limited access to healthcare facilities, particularly in rural and hard-to-reach areas. Collaboration with other government entities and the private sector improved vaccine access.
导语:尽管全球市场形势复杂,博茨瓦纳在2021年3月至2022年3月期间购买了约260万剂COVID-19疫苗,其中76%为购买,24%为捐赠。因此,该研究旨在收集有关博茨瓦纳COVID-19疫苗获取模式、犹豫和接受情况的证据。材料和方法:我们对基于博茨瓦纳的文章进行了范围审查,使用预定的搜索策略搜索数据库,包括Medline, CINAHL, Web of Science, PubMed, Scopus和谷歌Scholar。审查纳入了所有关于博茨瓦纳疫苗接种的英文书面同行评议文献和灰色文献,以扩大覆盖面,认识到博茨瓦纳关于COVID-19疫苗接种的出版物有限。由于翻译资源有限,非英文文章被排除在外。由于研究的异质性,我们采用叙事综合方法来收集、综合和绘制文献。结果:截至2021年12月31日,博茨瓦纳18岁以上人口1390856人的国家目标中,有80.6%的人至少接种了一剂COVID-19疫苗,而71.9%的人接种了完全疫苗。利用了各种疫苗分发渠道,包括公共设施和外展活动,以改善疫苗的获取和吸收。COVID-19疫苗接受度普遍较高(成年人中为73.4%),并且与男性、合并症患者、非限制性宗教信仰患者以及年龄在55-64岁的人认为疫苗可以安全使用呈正相关。COVID-19疫苗的交付依赖于现有的扩大免疫规划(EPI)结构,因此经历了现有的扩大免疫规划挑战,包括缺乏运输、人力资源短缺和疫苗库存不足。结论:地区一级免疫规划表现不佳,其特点是免疫覆盖率下降和外展服务不足,加剧了疫苗获取方面的差距。加强保健基础设施和扩大外联服务的努力对于接触到获得保健设施的机会有限的人口,特别是农村和交通不便地区的人口至关重要。与其他政府实体和私营部门的合作改善了疫苗的获取。